Skip to content
V-Biognostics
Toggle menu
  • About
  • Contact
  • Products
    • Osteocalcin (1-49) Human (Synthetic)
    • Antibiotics
      • Amphotericin B (Fungizone)
      • Bestatin (Ubenimex)
      • Bleomycin Sulfate
      • Brefeldin A
      • Daptomycin
      • G418, Sulfate
      • Mitomycin C
      • Thiostrepton
      • Valinomycin
    • Protease Inhibitors 1
      • AEBSF
      • Alafosfalin (Synthetic)
      • ALLN (Calpain Inh. I)
      • ALLM (Calpain Inh. II)
      • Amastatin, HCl
      • Antipain, 2HCl
      • Bestatin, HCl
      • Calpain Inh. III
      • Calpeptin
    • Protease Inhibitors 2
      • E-64 (Synthetic)
      • E-64d
      • Elastase Inh. I
      • Leupeptin, HCl
      • Leupeptin, Hemisulfate
      • MG-132
      • Pepstatin A
      • Phosphoramidon
      • RG108
      • TLCK, HCl
  • GERBU
    • GERBU Esterquat Product List
    • GERBU Adjuvant Product List
    • GERBU Adjuvant Introduction
    • GERBU Adjuvants Product Manuals
  • Articles
  • Email Logo

Category: News

May 17, 2022News

How infections spread: the case for varied and dynamic inputs

BioTechniques News Aisha Al-Janabi Understanding infectious disease spread is problematic, given the randomness of most outbreaks. Yet attempting to predict the transmission […]

May 17, 2022News

Depression increases the risk of cardiovascular disease

BioTechniques News Aisha Al-Janabi Depression and stress were discovered to impact cardiovascular disease and the effectiveness of cholesterol-lowering treatment in a mouse […]

May 16, 2022News

Targeting HOX genes to treat glioblastoma

BioTechniques News Aisha Al-Janabi A new potential treatment for the devastating brain cancer, glioblastoma, is ready for patient trials.  Glioblastoma – also […]

May 13, 2022News

Frozen tissues and Tabula Sapiens: the latest studies from the Human Cell Atlas

BioTechniques News Aisha Al-Janabi The latest studies published by The Human Cell Atlas make further progress toward their goal of mapping every […]

May 12, 2022News

Reference map of retinal pigment epithelium cells created with AI

BioTechniques News Georgia Bickerton Researchers identify five distinct cell subpopulations in the retinal pigment epithelium using artificial intelligence, which could explain different […]

May 11, 2022News

The burgeoning role of pharmacogenetics testing: the future of personalized medicine

BioTechniques News Aisha Al-Janabi David Budd, CEO of genedrive plc (Manchester, UK), underscores the emerging role of pharmacogenetics testing in patient safety […]

May 10, 2022News

Electric shocks manipulate cellular biofilm composition

BioTechniques News Aisha Al-Janabi Researchers use electrochemical signals to stimulate the proliferation of different cells in biofilms, which controls their growth.   Biofilms […]

May 9, 2022News

You really do want it more: cravings hit harder during withdrawal

BioTechniques News Aisha Al-Janabi A new study in rats finds that environmental stimuli learned during the withdrawal stage of alcohol addiction results […]

May 6, 2022News

How effective are Killer T cells against COVID-19?

BioTechniques News Tristan Free An artificial intelligence-based platform allows researchers to uncover the secrets behind adaptive immunity and killer T cells. Researchers […]

May 6, 2022News

Is salt the key to accurate breast cancer diagnosis?

BioTechniques News Georgia Bickerton A new sodium MRI technique could be used for breast cancer diagnosis and monitoring. Breast cancer is the […]

May 4, 2022News

Ta-dA! New mitochondrial gene editing development achieves A–G base conversion

BioTechniques News Aisha Al-Janabi Scientists use a single strand DNA-targeting protein for A–G base conversion, in a significant mitochondrial gene-editing technological breakthrough. […]

April 29, 2022News

Protein identified allowing Sclerotinia sclerotiorum to destroy crops

BioTechniques News Georgia Bickerton Researchers have identified the protein that allows white mold stem rot to bypass plants’ defenses, which could lead […]

April 28, 2022News

Understanding the disease trajectory of Long COVID

BioTechniques News Aisha Al-Janabi UCLA researchers reveal that 30% of people treated for COVID-19 developed Long COVID and link factors correlated to […]

April 26, 2022News

Ultrasound mechanically destroys liver cancer tumors

BioTechniques News Georgia Bickerton Researchers evaluate tumor recurrence and metastases after using a non-invasive ultrasound treatment, called histotripsy, on liver cancer in […]

April 25, 2022News

From the floor at AACR 2022: a video roundup

BioTechniques News Tristan Free At this year’s meeting of the American Association for Cancer Research (8th-13th April; New Orleans, LA, USA) we […]

April 25, 2022News

Is The Earth BioGenome Project a success story for whole-genome sequencing? Find out in your latest issue of BioTechniques

BioTechniques News Aisha Al-Janabi In this issue of BioTechniques, we present an artificial intelligence-powered time-lapse imaging microscopy method for studying T cells, […]

April 25, 2022News

I spy with my little eye developments towards a color-sensing ‘electric eye’

BioTechniques News Aisha Al-Janabi A team of researchers has made progress towards developing an ‘electric eye’ with improved color recognition, using a […]

April 22, 2022News

New study identifies subset of T cells that regulate the immune system

BioTechniques News Georgia Bickerton Researchers find that blocking the checkpoint protein PD-L1 unexpectedly activates regulatory T cells (effector Tregs), reducing the ability […]

April 21, 2022News

The five diseases behind language impairment

BioTechniques News Aisha Al-Janabi An extensive autopsy study identifies diseases that cause progressive impairments of language, such as difficulty with grammar or […]

April 20, 2022News

Understanding disparities in Alzheimer’s disease: an interview with Renã Robinson

BioTechniques News Tristan Free US statistics indicate that older African Americans and Hispanics are 2–3 times more likely to develop Alzheimer’s disease […]

Posts navigation

< 1 … 23 24 25 … 48 >
Partnering with:   Quartett GERBU Adjuvants

V-BIOGNOSTICS, "Ingredients For Life" is a BioTech company devoted to research in life science reagents worldwide. We source difficult to find biochemicals for the advancement in research of antibody production, Immunohistochemistry, drug development, molecular biology, cell biology, cancer research, Immunotherapy, Oncology, drug discovery, and agricultural biotechnology. We work hard for speedy processing and delivery of your products and at very competitive pricing offering you a high quality alternative to big pharma for your sourcing and manufacturing needs.

D&B VERIFIED Seal

We Supply the highest quality protease inhibitors, antibiotics, and Adjuvants including: Bestatin HCl, Leupeptin Hemisulfate / Hydrochloride, AEBSF, G418, Elastatinal, E-64, Pepstatin, Calpain, Bleomycin Sulfate, Proteinase K, MG-132, ALLM, ALLN, Antipain, Anti-Human Rabbit IgG, GERBU Monoclonal/Polyclonal Adjuvant, synthetic and custom synthesis. Please Contact Us or visit our Products, About, or Terms pages for more information.

Biotech Articles

  • New ‘asthma-on-a-chip’ technology opens the door to future treatments
  • Breast milk nutrient shapes immune development in mice
  • A targeted paper shredder for the genome: new CRISPR tech tears up diseased cells’ DNA
  • The biotech bi-weekly: partnerships facilitating antibody discovery and AI drug development
  • New gene therapy reverses Fragile X deficits in preclinical model
  • May I have your attention, please: ancient neurons hold ADHD clues
© 2026 V-Biognostics. Proudly powered by Sydney